Header Logo

Connection

TARIQ SHAFI to Middle Aged

Back to Details
This is a "connection" page, showing publications TARIQ SHAFI has written about Middle Aged.
TARIQ SHAFI
Connection Strength
1.226
Middle Aged
  1. Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study. Ann Intern Med. 2022 08; 175(8):1073-1082.
    View in: PubMed
    Score: 0.045
  2. Patients' and family members' perspectives on arrhythmias and sudden death in dialysis: the HeartLink focus groups pilot study. BMC Nephrol. 2021 05 27; 22(1):199.
    View in: PubMed
    Score: 0.041
  3. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. 2020 05 01; 35(5):846-853.
    View in: PubMed
    Score: 0.038
  4. Prevalence and Persistence of Uremic Symptoms in Incident Dialysis Patients. Kidney360. 2020 Feb; 1(2):86-92.
    View in: PubMed
    Score: 0.038
  5. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019 04 25; 20(1):138.
    View in: PubMed
    Score: 0.036
  6. Serum Metabolites and Cardiac Death in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2019 05 07; 14(5):747-749.
    View in: PubMed
    Score: 0.036
  7. Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients. BMC Nephrol. 2017 Oct 10; 18(1):309.
    View in: PubMed
    Score: 0.032
  8. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated?with?cardiovascular outcomes. Kidney Int. 2017 12; 92(6):1484-1492.
    View in: PubMed
    Score: 0.032
  9. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore). 2017 Feb; 96(5):e5924.
    View in: PubMed
    Score: 0.031
  10. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2017 Jul; 70(1):48-58.
    View in: PubMed
    Score: 0.031
  11. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol. 2017 Jan; 28(1):321-331.
    View in: PubMed
    Score: 0.030
  12. Hand-carried ultrasound use in clinical nephrology: Case report. Medicine (Baltimore). 2016 Jul; 95(30):e4166.
    View in: PubMed
    Score: 0.029
  13. Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
    View in: PubMed
    Score: 0.029
  14. Estimating residual kidney function in dialysis patients without urine collection. Kidney Int. 2016 May; 89(5):1099-1110.
    View in: PubMed
    Score: 0.029
  15. Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients. Am J Kidney Dis. 2015 Oct; 66(4):728-30.
    View in: PubMed
    Score: 0.028
  16. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators. PLoS One. 2015; 10(5):e0126048.
    View in: PubMed
    Score: 0.027
  17. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014 Sep; 64(3):443-51.
    View in: PubMed
    Score: 0.025
  18. Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol. 2014 Apr; 25(4):799-809.
    View in: PubMed
    Score: 0.025
  19. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013 Jun; 36(6):1522-33.
    View in: PubMed
    Score: 0.023
  20. Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
    View in: PubMed
    Score: 0.022
  21. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol. 2012 Jun 15; 13:42.
    View in: PubMed
    Score: 0.022
  22. Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reduction. Medicine (Baltimore). 2011 Sep; 90(5):296-302.
    View in: PubMed
    Score: 0.021
  23. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug; 56(2):348-58.
    View in: PubMed
    Score: 0.019
  24. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008 Dec; 52(6):1022-9.
    View in: PubMed
    Score: 0.017
  25. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
    View in: PubMed
    Score: 0.014
  26. Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies. Nat Commun. 2025 Nov 27; 16(1):11689.
    View in: PubMed
    Score: 0.014
  27. Machine learning-based prediction models in medical decision-making in kidney disease: patient, caregiver, and clinician perspectives on trust and appropriate use. J Am Med Inform Assoc. 2025 01 01; 32(1):51-62.
    View in: PubMed
    Score: 0.013
  28. Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis. Am J Kidney Dis. 2024 07; 84(1):73-82.
    View in: PubMed
    Score: 0.013
  29. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2024 07; 84(1):49-61.e1.
    View in: PubMed
    Score: 0.012
  30. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 04 05; 11(7):e022891.
    View in: PubMed
    Score: 0.011
  31. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. J Am Soc Nephrol. 2022 03; 33(3):601-611.
    View in: PubMed
    Score: 0.011
  32. Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study. Mayo Clin Proc. 2022 01; 97(1):78-87.
    View in: PubMed
    Score: 0.011
  33. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. N Engl J Med. 2021 11 04; 385(19):1750-1760.
    View in: PubMed
    Score: 0.011
  34. Kidney Disease Symptoms before and after Kidney Transplantation. Clin J Am Soc Nephrol. 2021 07; 16(7):1083-1093.
    View in: PubMed
    Score: 0.010
  35. Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort. Am J Nephrol. 2021; 52(2):141-151.
    View in: PubMed
    Score: 0.010
  36. Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2021 03; 32(3):639-653.
    View in: PubMed
    Score: 0.010
  37. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
    View in: PubMed
    Score: 0.010
  38. Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.
    View in: PubMed
    Score: 0.010
  39. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
    View in: PubMed
    Score: 0.010
  40. Performance of Indexed and Nonindexed Estimated GFR. Am J Kidney Dis. 2020 09; 76(3):446-449.
    View in: PubMed
    Score: 0.010
  41. Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study. J Am Soc Nephrol. 2020 04; 31(4):817-827.
    View in: PubMed
    Score: 0.010
  42. Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection. Perit Dial Int. 2020 01; 40(1):84-92.
    View in: PubMed
    Score: 0.009
  43. Lower levels of proteinuria are associated with elevated mortality in incident dialysis patients. PLoS One. 2019; 14(12):e0226866.
    View in: PubMed
    Score: 0.009
  44. Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodial Int. 2020 01; 24(1):43-51.
    View in: PubMed
    Score: 0.009
  45. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.009
  46. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
    View in: PubMed
    Score: 0.009
  47. Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrol Dial Transplant. 2019 05 01; 34(5):825-833.
    View in: PubMed
    Score: 0.009
  48. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. JAMA Intern Med. 2019 04 01; 179(4):542-551.
    View in: PubMed
    Score: 0.009
  49. Hepatitis B virus infection and development of chronic kidney disease: a cohort study. BMC Nephrol. 2018 12 11; 19(1):353.
    View in: PubMed
    Score: 0.009
  50. Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018; 48(5):330-338.
    View in: PubMed
    Score: 0.009
  51. Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients. Am J Nephrol. 2018; 48(3):181-189.
    View in: PubMed
    Score: 0.009
  52. Effects of Body Size and Composition on Sex Differences in Measured GFR in a US?Community-Based Older Cohort (MESA-Kidney). Am J Kidney Dis. 2018 11; 72(5):767-770.
    View in: PubMed
    Score: 0.008
  53. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018 07 01; 33(7):1215-1223.
    View in: PubMed
    Score: 0.008
  54. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018 06 26; 19(1):150.
    View in: PubMed
    Score: 0.008
  55. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep. 2018 03 16; 8(1):4718.
    View in: PubMed
    Score: 0.008
  56. Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis. Nephrol Dial Transplant. 2018 03 01; 33(3):417-425.
    View in: PubMed
    Score: 0.008
  57. Metabolomic Alterations Associated with Cause of CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1787-1794.
    View in: PubMed
    Score: 0.008
  58. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
    View in: PubMed
    Score: 0.008
  59. Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO. Medicine (Baltimore). 2017 Feb; 96(6):e5799.
    View in: PubMed
    Score: 0.008
  60. Intravenous iron administration strategies and anemia management in hemodialysis patients. Nephrol Dial Transplant. 2017 01 01; 32(1):173-181.
    View in: PubMed
    Score: 0.008
  61. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate. Nephrol Dial Transplant. 2016 08; 31(8):1335-41.
    View in: PubMed
    Score: 0.007
  62. Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study. J Am Soc Nephrol. 2016 Nov; 27(11):3469-3478.
    View in: PubMed
    Score: 0.007
  63. GFR Estimation Using ?-Trace Protein and ?2-Microglobulin in?CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8.
    View in: PubMed
    Score: 0.007
  64. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015; 42(1):25-34.
    View in: PubMed
    Score: 0.007
  65. A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis. BMC Nephrol. 2015 Aug 14; 16:138.
    View in: PubMed
    Score: 0.007
  66. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Aug 07; 16:131.
    View in: PubMed
    Score: 0.007
  67. The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant. 2015 Nov; 30(11):1870-7.
    View in: PubMed
    Score: 0.007
  68. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
    View in: PubMed
    Score: 0.007
  69. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant. 2015 Apr; 30(4):667-75.
    View in: PubMed
    Score: 0.007
  70. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1930-9.
    View in: PubMed
    Score: 0.007
  71. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014 Dec; 64(6):954-61.
    View in: PubMed
    Score: 0.007
  72. Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. BMC Nephrol. 2014 May 01; 15:68.
    View in: PubMed
    Score: 0.006
  73. An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. Kidney Int. 2014 Oct; 86(4):798-809.
    View in: PubMed
    Score: 0.006
  74. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.006
  75. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
    View in: PubMed
    Score: 0.006
  76. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol. 2013 Dec 01; 14:264.
    View in: PubMed
    Score: 0.006
  77. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12; 14:249.
    View in: PubMed
    Score: 0.006
  78. Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol. 2014 Feb; 25(2):370-9.
    View in: PubMed
    Score: 0.006
  79. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014 Feb; 29(2):290-7.
    View in: PubMed
    Score: 0.006
  80. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol. 2013 Jun 27; 14:134.
    View in: PubMed
    Score: 0.006
  81. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013 Jun; 61(6):966-74.
    View in: PubMed
    Score: 0.006
  82. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
    View in: PubMed
    Score: 0.006
  83. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012 May; 59(5):653-62.
    View in: PubMed
    Score: 0.005
  84. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2011 May; 93(5):1087-91.
    View in: PubMed
    Score: 0.005
  85. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2010 Oct 25; 170(19):1745-51.
    View in: PubMed
    Score: 0.005
  86. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension. 2004 Jun; 43(6):1202-7.
    View in: PubMed
    Score: 0.003
  87. Transradial diagnostic and percutaneous coronary intervention. J Coll Physicians Surg Pak. 2003 May; 13(5):242-7.
    View in: PubMed
    Score: 0.003
  88. Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol. 2002 Oct; 119(1):144-54.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.